Draft FDA Guidance & a Magic Wand
2023-06-23 Now that we’ve all reviewed the Draft FDA Guidance around DCTs, what would you do if you had a magic wand? If you were the decision maker, how would you take what was offered in the guidance and go further? Hosts Craig Lipset, Amir Kalali, and Jane Myles were joined by Jonathan Andrus (CRIO) and Dylan Bechtle (The Janssen Pharmaceutical Companies of Johnson & Johnson) for the discussion.
Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and Twitter. Learn more about Membership and our work at www.dtra.org.
